Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pulmonary Hypertension, Hypoxia and Sickle Cell Disease

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) ) Identifier:
First received: June 30, 2007
Last updated: December 3, 2014
Last verified: December 2014